Enovis (ENOV) Asset Writedowns and Impairment (2018 - 2025)

Enovis (ENOV) has 6 years of Asset Writedowns and Impairment data on file, last reported at $501.3 million in Q4 2025.

• Quarterly Asset Writedowns and Impairment fell 22.91% year-over-year to $501.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.7 billion (up 160.57% YoY) and the FY2025 annual result came in at $1.0 billion, up 61.42% from the prior year.
• Asset Writedowns and Impairment declined to $501.3 million in Q4 2025 per ENOV's latest filing, from $548.4 million in the prior quarter.
• Across five years, Asset Writedowns and Impairment topped out at $650.3 million in Q4 2024 and bottomed at -$67.8 million in Q2 2024.
• The 3-year median for Asset Writedowns and Impairment is $62.7 million (2023), against an average of $212.5 million.
• The widest annual swing landed in 2024, when Asset Writedowns and Impairment tumbled 30.5%; it then surged 9972.94% in 2025.
• Tracing ENOV's Asset Writedowns and Impairment over 3 years: stood at -$52.0 million in 2023, then soared by 1350.81% to $650.3 million in 2024, then declined by 22.91% to $501.3 million in 2025.
• Per Business Quant, the three latest ENOV Asset Writedowns and Impairment figures stand at $501.3 million (Q4 2025), $548.4 million (Q4 2025), and $650.3 million (Q4 2024).

Peer Comparison